- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | |
|---|---|---|---|---|
| ACUCORT Aktie jetzt für 0€ handeln | ||||
| 18.06. | ACUCORT AB: LSIF invests SEK 1 million in AcuCort through exercise of warrants - strong support ahead of final day for exercising TO 2 | 2 | Cision News | |
| 17.06. | ACUCORT AB: AcuCort signs Letter of Intent (LOI) with Glenmark Pharmaceuticals for Germany and five additional European countries | 2 | Cision News | |
| 11.06. | Spotlight Stock Market: Market Notice 107/25 - Last day of trading in AcuCort AB's subscription option ACUC TO 2 | 5 | Cision News | |
| 10.06. | ACUCORT AB: AcuCort signs Letter of Intent (LOI) with Lunatus for the Middle East and Gulf States | 1 | Cision News | |
| 26.05. | ACUCORT AB: AcuCort's drug Zeqmelit registered as a trademark in Canada | 2 | Cision News | |
| 12.05. | ACUCORT AB: AcuCort receives new order for Zeqmelit® - strong development in the Nordic market | 1 | Cision News | |
| 01.04. | ACUCORT AB: AcuCort receives new order for Zeqmelit® and begin Danish expansion | 2 | Cision News | |
| 19.03. | ACUCORT AB: AcuCort receives renewed marketing authorisation for Zeqmelit® in Norway | 1 | Cision News | |
| 17.03. | ACUCORT AB: AcuCort receives renewed marketing authorisation for Zeqmelit® in Denmark | 1 | Cision News | |
| 04.03. | ACUCORT AB: AcuCort's medicinal product receives renewed marketing authorisation from the Swedish Medical Products Agency | 2 | Cision News | |
| 13.02. | Spotlight Stock Market: Market Notice 37/25 - Information regarding AcuCort AB's subscription option | - | Cision News | |
| 10.02. | Spotlight Stock Market: Market Notice 35/25 - Last day of trading in AcuCort AB's BTU | 1 | Cision News | |
| 27.01. | ACUCORT AB: Promising results from AcuCort's Phase IV study - scientific articles under preparation for international publication | 1 | Cision News | |
| 17.01. | ACUCORT AB: AcuCort's Chairman subscribes for an additional approximately SEK 200,000 in the ongoing rights issue | 1 | Cision News | |
| 14.01. | ACUCORT AB: AcuCort's CEO subscribes for an additional SEK 1 million in the ongoing rights issue, bringing total commitment to approximately SEK 2 million | 1 | Cision News |
15 Nachrichten in den letzten 12 Monaten
ACUCORT AB gehört der Branche Pharma an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 0,053 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ACUCORT AB finden Sie auf Wallstreet Online.